NCT01503957已完成3 期
Double-blind, Randomized, Placebo-controlled, Crossover Clinical Investigation to Evaluate Safety and Efficacy of Nasya in Reducing Symptoms of Allergic Rhinitis When Applied Before Allergen Challenge
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 20
- 试验地点
- 2
- 主要终点
- Difference in Total Nasal Symptom Score
研究概览
简要总结
The purpose of this study is to evaluate safety and efficacy of Nasya in reducing symptoms of persistent allergic rhinitis when applied before allergen challenge.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Prevention
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 60 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •History of persistent allergic rhinitis due to house dust mite allergy ≥ 2 years
- •Written informed consent
排除标准
- •Clinically significant disease that could interfere with the evaluation of study medication
- •Participation in other studies within the last 4 weeks / during the study
结局指标
主要结局
Difference in Total Nasal Symptom Score
时间窗: 75 minutes
次要结局
- Difference in Total Nasal Symptom Score(Up to 240 minutes)
- Difference in Total Ocular Symptom Score(Up to 240 minutes)
研究者
研究点 (2)
Loading locations...
相似试验
撤回
2 期
Efficacy and Safety of Nitazoxanide for Post Exposure Prophylaxis of COVID-19covid19NCT04435314Azidus Brasil
终止
4 期
An Efficacy and Safety Study of Cisapride for Improving Symptoms Associated With Gastroparesis in Patients With Diabetes MellitusDiabetes MellitusGastroparesisNCT01286090Johnson & Johnson Pharmaceutical Research & Development, L.L.C.4
尚未招募
不适用
Clinical Study of De-Stress & Happy Gut Powder for Stress and Indigestion in Adults.StressIndigestionDyspepsiaNCT06568965Herbolab India Pvt. Ltd.81
Unknown
不适用
Effects of Sulforaphane in Patients With Prodromal to Mild Alzheimer's DiseaseAlzheimer DiseaseNCT04213391Second Affiliated Hospital, School of Medicine, Zhejiang University160
已完成
3 期
Sodium Picosulphate vs. Placebo in Functional ConstipationConstipationNCT00576810Boehringer Ingelheim367